Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05910853
Status:
TERMINATED
Last Update Posted:
2024-04-18
First Post:
2023-06-08
Brief Title:
Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia
Sponsor:
Sanguine Biosciences
Organization:
Sanguine Biosciences
Study Overview
Official Title:
Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia
Status:
TERMINATED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Unable to recruit new subjects due to disease rarity
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary study objective is to collect biospecimen samples eg blood from participants diagnosed with Fanconi Anemia The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None